Equities

Doctor Care Anywhere Group PLC

DOC:ASX

Doctor Care Anywhere Group PLC

Actions
Health CareHealth Care Providers
  • Price (AUD)0.073
  • Today's Change0.002 / 2.82%
  • Shares traded182.60k
  • 1 Year change+32.73%
  • Beta2.3887
Data delayed at least 20 minutes, as of Sep 20 2024 06:20 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 19-Sep-24
Select bar for recommendation details.
Recommendations19-Sep-24
Buy0
Outperform1
Hold0
Sell0
Strong Sell0

Share price forecast in GBX

The one analyst offering a 12 month price target expects Doctor Care Anywhere Group PLC share price to rise to 0.1197 in the next year from the last price of 0.073.
High63.9%0.1197
Med63.9%0.1197
Low63.9%0.1197

Earnings history & estimates in GBX

Doctor Care Anywhere Group PLC reported annual 2023 losses of -3.00 per share on Feb 28, 2024.
Average growth rate+50.00%
More ▼

Revenue history & estimates in GBP

Doctor Care Anywhere Group PLC had revenues for the full year 2023 of 38.46m. This was 29.10% above the prior year's results.
Average growth rate+54.72%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.